Fournier gangrene
| Fournier gangrene | |
|---|---|
| File:File:Furnijerova gangrena.jpg | |
| Synonyms | |
| Pronounce | |
| Field | Infectious disease |
| Symptoms | |
| Complications | |
| Onset | |
| Duration | |
| Types | |
| Causes | |
| Risks | |
| Diagnosis | |
| Differential diagnosis | |
| Prevention | |
| Treatment | |
| Medication | |
| Prognosis | |
| Frequency | 1 per 62,500 males a year |
| Deaths | |
Fournier Gangrene is a rare and often severe form of necrotizing fasciitis or gangrene specifically affecting the external genitalia or perineum. It was first described by Baurienne in 1764 and later named after French venereologist Jean Alfred Fournier in 1883.
Introduction
Fournier Gangrene predominantly affects older men, but it can also occur in women and children. This condition is more commonly found in individuals with diabetes, alcoholism, or those who are immunocompromised. The condition is rare, with an incidence of about one per 62,500 males per year, and males are affected approximately 40 times more often than females.
Clinical Presentation
The initial symptoms of Fournier Gangrene include sudden pain in the scrotum, fever, pallor, and generalized weakness. The pain often extends beyond the area of visible redness on the skin (erythema). It typically begins as a subcutaneous infection, but necrotic patches soon appear on the overlying skin, which subsequently develop into full-blown necrosis.
Most cases of Fournier Gangrene present mildly but can progress rapidly within hours. More advanced cases are characterized by a foul odor and necrotic infected tissue. Subcutaneous air, detectable as crepitus (a crackling sensation under the skin), is often one of the specific clinical signs, but it is not seen in more than 50% of presenting clinical cases.
Treatment and Prognosis
The management of Fournier Gangrene involves prompt surgical debridement, broad-spectrum antibiotics, and supportive care. Despite aggressive treatment, the condition carries a high mortality rate, underscoring the importance of early recognition and management.
See Also
|
|
|
| Male diseases of the pelvis and genitals | ||||||
|---|---|---|---|---|---|---|
|
| Female diseases of the pelvis and genitals | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


